INSTINCT BIO TECHNICAL CO HOLDINGS INC.
corporate_fare Company Profile
INSTINCT BIO TECHNICAL CO HOLDINGS INC. (NASDAQ:BIOT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 5 items for BIOT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-15, rated 9/10. Across its 5 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for BIOT spans 6-K, 20-F.
Recent high-impact activity:
- Instinct Bio Hit With Three Nasdaq Delisting Notices
- BIOT to Launch Subscription Beauty Clinics in Indonesia, Targeting $500M Market
- Instinct Bio Closes SPAC Merger, Reveals $1.5M Negative Equity and $150M Equity Facility
- Instinct Bio Locks In $150M Equity Funding, 12x Its Market Cap
- Instinct Bio Lines Up $150M Equity Facility to Fuel Regenerative Medicine Ambitions
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 73,107 shares in BIOT as of the September 15, 2026 settlement, a 70.0% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 24.4% of BIOT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for BIOT, detected from its recent SEC filings · based on capital-structure filings through 2026-07-28.
$150M Equity Facility Proposed · Massive Dilution Overhang
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
BIOT files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.